Estrogen replacement therapy after endometrial cancer: a survey of physicians' prescribing practice

Objective To determine whether the prescribing practice of physicians with regard to estrogen replacement therapy (ERT) in symptomatic women with previous endometrial cancer is consistent with the available evidence. Methods A descriptive survey was conducted among physicians in Germany, using a que...

Full description

Saved in:
Bibliographic Details
Published in:Climacteric : the journal of the International Menopause Society 2010-06, Vol.13 (3), p.271-277
Main Authors: Hancke, K., Foeldi, M., Zahradnik, H. P., Gitsch, G., Gilbert, L., Denschlag, D.
Format: Article
Language:English
Subjects:
Adenocarcinoma - complications
Adenocarcinoma - pathology
Attitude of Health Personnel
Contraindications
ENDOMETRIAL CANCER
Endometrial Neoplasms - complications
Endometrial Neoplasms - pathology
ESTROGEN REPLACEMENT THERAPY
Estrogens
Female
Germany
HORMONE REPLACEMENT THERAPY
Hot Flashes - drug therapy
Humans
Libido
Menopause
Phytoestrogens - therapeutic use
Practice Patterns, Physicians' - statistics & numerical data
PRESCRIBING PRACTICE
Risk Assessment
Risk factors
Serotonin Uptake Inhibitors - therapeutic use
SURVEY
Surveys and Questionnaires
Women
Womens health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective To determine whether the prescribing practice of physicians with regard to estrogen replacement therapy (ERT) in symptomatic women with previous endometrial cancer is consistent with the available evidence. Methods A descriptive survey was conducted among physicians in Germany, using a questionnaire containing two hypothetical cases of endometrial cancer patients ('low-risk' and 'high-risk' disease) and menopausal symptoms. Physicians were asked about their prescribing practice concerning moderate to severe menopausal symptoms. Results Four hundred and twenty questionnaires were sent out, with an overall response rate of 39.8%; 45.6% in the 'low-risk' case and 75.4% in the 'high-risk' case (p 
ISSN:1369-7137
1473-0804
DOI:10.3109/13697130903131338